drugset / Trial / NCT01312766

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

NCT01312766

Phase 3 Completed 270 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous hMG preparations when administered to patients undergoing controlled ovarian stimulation for IVF.

Timeline

Start
2011-02
Primary completion
2013-04
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Menopur Protein / enzyme biologic 150 iu Subcutaneous
Comparator Menopur Protein / enzyme biologic 225 iu Subcutaneous

Indications